Eiichiro Kanda News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eiichiro kanda. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eiichiro Kanda Today - Breaking & Trending Today

168th Health Research Report 16 NOV 2013

168 Health Research Report WHITE PAPER /ROUGH COPY 168th Issue Date 16 NOV 2013 Compiled By Ralph Turchiano www.vit.bz www.youtube.com/vhfilm www.engineeringevil.com www.healthresearchreport.me In this Issue: 1. The most commonly prescribed treatment for Colds and Sore Throats offers no benefit and may actually make the illness worse 2. Japanese super food prevents flu infection 3. Study… ....

New York , United States , San Diego , United Kingdom , University Of Adelaide , South Australia , France General , Stanford University , Thomas Leung , Raffi Aroian , Magdalena Cuenca Garc , Joseu Scher , Seung Kim , Steven Abramson , Matthewj Rossman , Nimrit Goraya , Randys Longman , Naoko Waki , Christopher Mcdevitt , Martins Kimmel , Ralph Turchiano , Denisa Ferastraoaru , Rupert Payne , Susan Knox , Frederickh King , Danr Littman ,

RAASi Rechallenge Uncommon After Hyperkalemia, Tied With Adverse Outcomes

Investigators assessed the extent of RAASi discontinuation after a hyperkalemia episode in cardiorenal patients and its effect on hospital length of stay. ....

United States , Sanjay Rastogi , Eiichiro Kanda , European Renal Association , Kawasaki Medical School In Okayama , Kawasaki Medical School , Clinical Chief , Observational Study , Cardiorenal Patients ,

Suboptimal RAASi Therapy After Hyperkalemia Ups Cardiorenal Risks

Hyperkalemia frequently results in suboptimal use of renin-angiotensin-aldosterone system inhibitor (RAASi) therapy and cardiorenal risks. ....

Eiichiro Kanda , Kawasaki Medical School In Okayama , Kawasaki Medical School , Market Clarity Data , Medical Data Vision ,

Suboptimal RAASi Therapy After Hyperkalemia Ups Cardiorenal Risks

Hyperkalemia frequently results in suboptimal use of renin-angiotensin-aldosterone system inhibitor (RAASi) therapy and cardiorenal risks. ....

Eiichiro Kanda , Kawasaki Medical School In Okayama , Kawasaki Medical School , United States , Market Clarity Data , Medical Data Vision ,

Potassium Binder Use Long Term Linked With Better Outcomes

In a real-world study, investigators examined potassium binder adherence and the risk for adverse outcomes. ....

United States , Eiichiro Kanda , Kawasaki Medical School In Kurashiki , American Society Of Nephrology Kidney Week , American Society , Kidney Week , Kawasaki Medical School ,